Y. Tuininga, H. J. Crinjns, C. Kozma
Jun 1, 1994
Citations
0
Influential Citations
0
Citations
Quality indicators
Journal
International journal of clinical pharmacology and therapeutics
Abstract
Restacorin is a recently developed effective antiarrhythmic agent with primarily class Ic properties. The present paper reviews the electrophysiologic and hemodynamic effects of this compound. The major electrophysiologic effects are a depression of Vmax and an increase in AH, HV and QRS duration. The administration of restacorin does not induce significant side effects. In subjects with a normal left ventricular function, restacorin does not show negative inotropic effects. However, in patients with a decreased left ventricular function, restocorin produces a moderate negative inotropic effect.